Study Shows Abraxane® Extends Survival For Patients With Advanced Pancreatic Cancer -- MANHATTAN BEACH, Calif., Nov. 9, 2012 /PRNewswire/ --

Nov 9 2012

Download image

MANHATTAN BEACH, Calif., Nov. 9, 2012 /PRNewswire/ -- The Pancreatic Cancer Action Network is pleased to announce Abraxane® extends survival for patients with advanced pancreatic cancer. According to Celgene Corporation, Abraxane in combination with gemcitabine when given to advanced pancreatic cancer patients who had not received previous treatment demonstrated a statistically significant improvement in overall survival compared to patients receiving gemcitabine alone.

(Logo: http://photos.prnewswire.com/prnh/20111004/LA79914LOGO)

The phase III study included 861 metastatic pancreatic cancer patients from around the world. Full results from the clinical trial will be presented at the American Society of Clinical Oncology's 2013 Gastrointestinal Cancers Symposium being held in January.

"Historically, few effective treatment options for pancreatic cancer have existed. We are thrilled to have a new treatment option for patients with advanced pancreatic cancer. We look forward to learning more about the increase in survival when the full results from the study are released in January," stated Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network. "Clinical trials represent hope for patients with pancreatic cancer and we are so appreciative of the patients who participated in this study. It is the only way to make progress towards better treatments."

Abraxane was previously approved for breast cancer in 2005 and last month was approved for a type of lung cancer. It is a form of the chemotherapy drug paclitaxel that is modified by the addition of a human protein called albumin. The company plans to submit the drug to the FDA for approval in pancreatic cancer.

The Pancreatic Cancer Action Network encourages all patients to consider clinical trials when exploring treatment options. Our organization has a comprehensive up-to-date database of all approved pancreatic cancer-specific clinical trials taking place nationwide and can do a customized eligibility search for patients through our Patient and Liaison Services program.

For more information about the Pancreatic Cancer Action Network and clinical trials visit www.pancan.org.

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.

SOURCE Pancreatic Cancer Action Network

Questions?

Can I help you? Drop me a line and let me know.

Contact Christine

Blogger Services

Customized Newsfeeds

Don't let the name PR Newswire for Journalists dissuade you. This is a great service for bloggers. Any content creator -- whether you're a journalist, freelancer or blogger -- can set up a customized profile to receive releases based on preferences. You also have access to hi-res photos, media-only content such as media advisories and embargoed releases, and experts via ProfNet.

ProfNet

Need expert sources? Check out ProfNet, a service that helps journalists, bloggers, authors, and other content creators connect with experts -- at no charge. Sending a query is easy: Just fill out a form detailing the kind of expertise you need, how you want to be contacted, and your deadline. ProfNet will do the rest. You also can sign up for a weekly "tip sheet" of experts and story ideas. Visit ProfNet for more info or go directly to the query form.

ProfNet Connect

ProfNet Connect is a free, interactive online community where PR professionals, experts, and media professionals can network and engage with one another. Via profiles, forums and blogs, subject-matter experts can position themselves as the go-to source for content creators and journalists. In turn, content creators can search the site by keyword to find the experts they need. The site also features enhanced profile capabilities, allowing users to easily add multimedia components -- photos, videos, white papers and more -- to their profiles.

News Widget

Our widget allows you to display PR Newswire content on your site with very little back-end programming required. You not only get the headline, but also the body of text of the news release, keeping the user on your site at all times. In order to do so, the difference between our Widget and other widgets is at the end of the sign-up process, you will be provided with two pieces of source code -- one for the page where the Widget itself will be displayed and one for the pages that will display the body of text of each news release. In addition, the sign-up process allows you to have 100 percent control over every aspect of the Widget's appearance, so that the Widget can blend in fully with the look and feel of your site. Still not convinced? Here's what one blogger had to say about the widget.

Search